search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
ANALYTICAL AND LAB EQUIPMENT


a pre-agreed schedule, can now be almost guaranteed because so many processes are automated. Similarly, equipment issues can be spotted and ironed out early in the process. Releasing products as soon as possible is helped by collating access from all the data across the systems involved. Similarly, sustainability has become increasingly important and being able to move data and information prevents repeat experiments and will improve efficiency. Being able to pinpoint and resolve bottle-necks will also lead to a smoother running facility.


tāBeing able


This diagram shows how data can lead to improved processes


WHY ARE HEALTH SCIENCE COMPANIES MORE ADVANCED? Although Michalle wasn’t able to say for sure why health science companies are more advanced than other manufacturing sectors in terms of managing and making different types of data available to the wider business (merging their IT and OT systems), she was willing to hazard a guess that it is because there are more siloed parts of a bio-sciences organisation than outfits in other sectors. These will likely include a research facility, a process development facility, a clinical manufacturing arm, and a commercial manufacturing or a contract manufacturing facility (CDMO). Companies also often work with external partners when developing and manufacturing new products. Similarly, it is probably the case that new products are coming on line in


health science companies more often than in some other sectors and these require nimbleness and agility as well as a concerted push to get products to market. This sharing of data is probably more necessary in international than smaller companies, and many health science companies work at scale. Although companies in the oil and gas sector, for example, are also huge, they deliver the same product consistently. Simiarly, the manufacture of parts in the process industry may not be subject to the same speed of change as those in the health sciences sector - although this is probably not the case for car components or computer chips which are likely to be subject to similar time-to-market pressures.


HOW EMERSON HELPS HEALTH SCIENCE CUSTOMERS Emerson provides a number of products that can help health companies manage their data. These include the DeltaV Automation System which ‘helps


Customer case studies When asked which companies Emerson works with in the health sciences


space, an apposite answer might be be ‘who doesn’t it work with?’ Some 29 of the top 30 health science companies use Emerson technology and these include Thermo Fischer, a company that has spoken about its advances in gene therapy as a result of Deltav Automation; and FujiFilm, a CDMO that increases speed to market using a cloning-across-sites system built on utilising Drug Substance Manufacturing (DSM) modules. These modules rely on Emerson’s DeltaV automation system and two DSM modules that share an Emerson Syncade manufacturing execution system (MES). Other customers include Bayer and Novo Nordisk.


12 www.scientistlive.com


o move and merge data and information from the IT and OT stacks has become essential for sustainability, efficiency and the smooth running of labs.


DeltaV workstations run on a specific set of preselected Dell computer hardware chosen to provide the best cost performance solution


eliminate complexity and project risk by offering contextualised data,’ according to the company. In addition, Emerson has developed other related technology for the health sciences sector that including the DeltaV Spectral Process Analytic Technology (PAT), a distributed process control system that uses spectral analysers to measure reflected light frequencies from on-line product samples. In 2021, the company also acquired a 55% stake in Aspentech in a bid to accelerate its industrial software strategy. Aspentech currently provides a range of data focused applications including twin technology as well as process automation simulation and other impressive tools to help health science companies deliver competitive advantage and cost savings. n


For more information visit https://www.emerson.com/


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60